Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

M2BPGi

  • You have access
    Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response
    NORIFUMI HARIMOTO, SHINJI ITOH, TAKAHIRO YAMANAKA, KEI HAGIWARA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, AKIRA WATANABE, KENICHIRO ARAKI, TOMOHARU YOSHIZUMI and KEN SHIRABE
    Anticancer Research January 2022, 42 (1) 245-251; DOI: https://doi.org/10.21873/anticanres.15479
  • You have access
    Predictors of Postoperative Ascites After Hepatic Resection in Patients With Hepatocellular Carcinoma
    NORIFUMI HARIMOTO, KENICHIRO ARAKI, NORIHIRO ISHII, RYO MURANUSHI, KOUKI HOSHINO, KEI HAGIWARA, MARIKO TSUKAGOSHI, TAKAMICHI IGARASHI, AKIRA WATANABE, NORIO KUBO and KEN SHIRABE
    Anticancer Research August 2020, 40 (8) 4343-4349; DOI: https://doi.org/10.21873/anticanres.14437
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire